2025 Annual Public Meeting of the Board of Directors

July 17, 2025
9-10:30am (eastern)

Each year, the Reagan-Udall Foundation for the FDA's Board of Directors conducts an annual public meeting to highlight our activities in support of the U.S. Food and Drug Administration. The meeting provides an opportunity for engagement among the Foundation's Board of Directors, FDA, and external stakeholders.

This year's meeting included a discussion about Agency priorities with senior FDA leaders:

Makary, Traficant, Zeta

Review the slides

Agenda

9am

Welcome & Call to Order

  • Richard L. Schilsky, MD, FACP, FSCT, FASCO
    Foundation Board Chair, Reagan-Udall Foundation for the FDA

FDA Leadership Discussion

  • Martin Makary, MD, MPH
    Commissioner of Food and Drugs, FDA
     
  • Jim Traficant
    Chief of Staff, FDA
     
  • Lowell Zeta, JD
    Deputy Commissioner for Strategic Initiatives and Special Counsel, FDA

Susan C. Winckler, RPh, Esq. (moderator)

Foundation Highlights

  • Richard L. Schilsky and Susan C. Winckler

Panel Discussion with Foundation Board Members

  • Edward John Allera, JD
     
  • Debra L. Ness, MS, Treasurer
     
  • Pietro Antonio Tataranni, MD
     
  • Andrew C. von Eschenbach, MD

Richard L. Schilsky (moderator)

10:30am

Closing Remarks & Adjourn